Welcome to our dedicated page for Elevance Health news (Ticker: ELV), a resource for investors and traders seeking the latest updates and insights on Elevance Health stock.
Elevance Health, Inc. (ELV) maintains this dedicated news hub for stakeholders tracking developments in health insurance innovation and corporate strategy. Access official press releases, regulatory filings, and operational updates from one of America's largest managers of Blue Cross Blue Shield plans and government-sponsored healthcare programs.
This resource provides investors with timely updates on earnings reports, Medicare Advantage expansions, and strategic partnerships. Analysts will find detailed information about risk management initiatives and market positioning within the competitive healthcare coverage sector.
Key content categories include quarterly financial disclosures, Medicaid program developments, provider network enhancements, and technology investments. All materials are sourced directly from corporate communications to ensure accuracy and compliance with financial reporting standards.
Bookmark this page for streamlined access to Elevance Health's latest announcements. Combine these updates with SEC filings and industry analysis for comprehensive due diligence on this leading health benefits administrator.
Elevance Health (NYSE:ELV) outlines how affiliated health plans are evolving to a whole-health model that integrates physical, behavioral and social needs to simplify care and improve outcomes.
The company highlights expanded access to doula care, community pharmacy programs across 500+ pharmacies, benefits for nutritious food, OTC medications and transportation, and digital access via the Sydney app. Elevance notes person-centered LTSS designations across 12 states and describes care managers who coordinate biopsies, community supports and services for members.
The release emphasizes data-driven care coordination, community partnerships, and personalized member support as drivers of improved affordability, quality and confidence in care navigation.
Elevance Health (NYSE: ELV) received multiple credit rating actions from AM Best on December 12, 2025: core BCBS-branded subsidiaries had their Financial Strength Rating affirmed at A (Excellent) and Long-Term ICRs affirmed at a+, while Wellpoint Life and Wellpoint West Virginia were upgraded to A / a+. Granular Insurance was upgraded to A / a (removed from review).
AM Best cited a very strong balance sheet (BCAR), consistent capital and surplus growth, access to a combined $5 billion revolver/commercial paper facility, and sound liquidity; it noted financial leverage at Elevance rose to ~42% but is expected to decline toward 40% by year-end 2025.
Elevance Health (NYSE: ELV) appointed Amy Schulman as an independent director, effective January 12, 2026. Schulman will join the Audit and Finance Committees and brings experience in healthcare innovation, regulatory strategy, and governance.
She is Managing Partner at Polaris Partners (managing $4 billion), Chair of the board at Alnylam Pharmaceuticals, and a Senior Lecturer at Harvard Business School. The board said the appointment supports its ongoing board refreshment and long-term shareholder value objectives.
Elevance Health (NYSE: ELV) announced on December 5, 2025 an expansion of its Virtual Assistant, a conversational digital experience available via the Sydney Health app and Elevance Health–affiliated health plan websites.
The Virtual Assistant provides personalized benefit explanations, in-network provider lists, and cost estimates in seconds, supports Spanish translation, and integrates with the Find Care platform. Early pilot results showed nearly 9 out of 10 users found answers using the tool. It is available now to approximately 22 million commercial plan members, with expansion to Medicare members planned for 2026. Availability may vary and is subject to state-specific approvals.
Elevance Health (NYSE: ELV) on November 24, 2025 outlined how it is using technology and personalized service to simplify access, build trust, and improve member loyalty.
The company described digital tools (mobile chat, AI-enabled identity/issue resolution), care managers and a “My Health Advocate” model in affiliated Medicare plans that match members with the same advocate for continuity. Programs cited include concierge care for conditions such as Crohn’s disease, cancer, behavioral health, and Type 2 diabetes. The company emphasized data protection, 24/7 convenience, and shifting from administrative insurer to lifetime health partner.
Elevance Health (NYSE: ELV) reported 3Q 2025 results with operating revenue $50.1B (up 12% vs. 3Q24) and diluted EPS $5.32 (adjusted $6.03). The company reaffirmed FY2025 guidance for a ~90.0% benefit expense ratio and adjusted diluted EPS ~ $30.00. Segment trends included Health Benefits revenue $42.2B and Carelon revenue $18.3B (up 33% YoY). Benefit expense ratio rose to 91.3% (+180 bps). Year-to-date capital returned totaled $3.3B; Q3 buybacks were $875M and the board has $7.2B repurchase authorization remaining.
Cash and investments at parent were about $2.6B as of Sept 30, 2025.
Elevance Health (NYSE: ELV) has scheduled its third quarter 2025 financial results announcement for October 21, 2025. The company will release results at 6:00 a.m. EDT, followed by a management conference call at 8:30 a.m. EDT to discuss the results and outlook.
Investors can access the conference call using specific dial-in numbers and access codes for both domestic and international participants. A replay will be available from 11:30 a.m. EDT on October 21 until November 21, 2025. Additionally, a live webcast will be accessible through the company's website at www.elevancehealth.com under the "Investors" section.
Elevance Health (NYSE:ELV) and the Impact Fitness Foundation have partnered to transform Northwest Middle School's weight room in Indianapolis. The renovation project, which marks the fourth fitness space upgrade in Indianapolis schools, includes new flooring, functional training equipment, and storage systems designed specifically for middle school students.
The initiative aligns with the Elevance Health Women's Fort Myers Tipoff basketball tournament and involved over 30 Elevance Health volunteers. The project aims to provide students with their first experience in a proper fitness facility, replacing previously outdated high school-level equipment that was unsuitable for middle school use.
Elevance Health (NYSE:ELV) has partnered with the National Association of Community Health Centers (NACHC) to integrate Food as Medicine (FAM) programming into primary care Community Health Centers (CHCs). The initiative expands Elevance's Nourished Well program by training CHC providers to connect Medicaid members at risk for diet-related chronic conditions with personalized nutrition support.
The partnership implements a three-pillar FAM Ecosystem Framework: food access & security through telehealth, clinical integration within primary care workflows, and culturally relevant lifestyle interventions. Additionally, the Elevance Health Foundation will provide a grant to NACHC to assess existing FAM programs, evaluate policies, and develop a scalable CHC model.
The program aims to enhance patient engagement, support chronic disease management, and strengthen preventive health efforts across CHCs serving 34 million patients nationwide. The long-term vision includes developing a Nutrition Center of Excellence as a national model for food-based clinical care.
Elevance Health (NYSE: ELV) has appointed Steve Collis to its Board of Directors, effective August 1, 2025. Collis, who currently serves as Executive Chairman of Cencora (formerly AmerisourceBergen), will join the board's Audit and Finance Committees.
Collis brings significant healthcare leadership experience, having served as President and CEO of Cencora from 2011 to 2024, where he led the company through strategic transformation and global expansion. The appointment aligns with Elevance Health's structured approach to board refreshment and strengthens its governance capabilities in support of the company's strategic objectives.
FAQ
What is the current stock price of Elevance Health (ELV)?
What is the market cap of Elevance Health (ELV)?
